Company intelligence / Profile preview
OncoTherapy Science, Inc.
Kawasaki City, Kanagawa Prefecture, Japanoncotherapy.co.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
OncoTherapy Science has advanced multiple programs into late-stage clinical trials. Lead candidates include elpamotide for metastatic pancreatic cancer and asudemotide for esophageal carcinoma—both in Phase 3. Other assets are in Phase 2 targeting mesothelioma and head & neck cancers. The company leverages genomics-driven target identification to develop molecular-targeted therapies with a focus on efficacy and safety. Recent activities include research progress on new compounds and development of a new cancer gene panel test via its subsidiary Cancer Precision Medicine Inc.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule drugstherapeutic vaccines (including peptide vaccines)antibody drugssynthetic peptide vaccinestherapeutic radiopharmaceuticals
- Industry
- Biotech
02
Drug pipeline
24 assets23 more assets in the full pipeline.
Beyond the preview
Go deeper on OncoTherapy Science, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OncoTherapy Science, Inc..